China SXT Pharmaceuticals, Inc. Increase (Decrease) in Accrued Liabilities
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-07-01
| Period end | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|
| 2026-03-31 | $244.08K 20-F · filed 2026-07-01 | |
| 2025-09-30 | $275.00K 6-K · filed 2025-12-31 | |
| 2025-03-31 | $298.76K 20-F · filed 2026-07-01 | |
| 2024-09-30 | $129.94K 6-K · filed 2025-12-31 | |
| 2024-03-31 | -$53.84K 20-F · filed 2026-07-01 | |
| 2023-09-30 | $308.02K 6-K · filed 2025-03-28 | |
| 2023-03-31 | -$46.37K 20-F · filed 2025-07-31 | |
| 2022-09-30 | $84.55K 6-K · filed 2024-04-05 | |
| 2022-03-31 | $384.80K 20-F · filed 2024-08-13 | |
| 2021-03-31 | $488.92K 20-F · filed 2023-07-31 | |
| 2020-03-31 | $1.61M 20-F/A · filed 2023-05-19 | |
| 2019-09-30 | -$145.50K 6-K/A · filed 2020-05-22 | |
| 2019-03-31 | $310.31K 20-F · filed 2021-08-13 | |
| 2018-09-30 | -$69.02K 6-K/A · filed 2020-05-22 | |
| 2018-03-31 | -$203.90K 20-F · filed 2020-07-31 | |
| 2017-03-31 | -$248.65K 20-F · filed 2019-08-15 |